Speaker Profile

Ph.D., CEO, Inflammatix

Biography
Dr. Sweeney cofounded Inflammatix following his clinical training as a surgeon at Stanford, where he was frequently frustrated with the lack of tools to determine which of his post-operative patients had infections and required antibiotics or evaluation for sepsis. He subsequently pursued post-doctoral research in biomedical informatics and, along with Inflammatix’s cofounder, Dr. Purvesh Khatri, developed the proprietary technology that powers the company’s tests, including its first test, HostDx Sepsis. Beyond his work at Inflammatix, Dr. Sweeney continues to actively give back to the community as a mentor to new startups in Stanford’s StartXMed program, as an editorial board member of Critical Care Medicine, and as a frequent ad-hoc peer reviewer for manuscripts in sepsis, bioinformatics, and machine learning.


 Session Abstract – PMWC Silicon Valley


The PMWC 2020 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.